• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

面对西那卡塞引起的低钙血症:坐视不管,放松心情?

Facing cinacalcet-induced hypocalcemia: sit back and relax?

机构信息

KU Leuven, Department of Immunology and Microbiology, Laboratory of Nephrology, Leuven, Belgium.

Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK.

出版信息

Kidney Int. 2018 Jun;93(6):1275-1277. doi: 10.1016/j.kint.2018.01.038.

DOI:10.1016/j.kint.2018.01.038
PMID:29792272
Abstract

A post hoc analysis of data from the EVOLVE study demonstrates that cinacalcet-induced hypocalcemia is common, mostly asymptomatic, and resolves spontaneously. These findings are reassuring and may warrant therapeutic inertia. However, previous studies in parathyroidectomized patients suggest that calcium repletion may be beneficial and safe from bone and cardiovascular perspectives, respectively, and as such call into question the appropriateness of a "sit back and relax" attitude toward cinacalcet-induced hypocalcemia.

摘要

EVOLVE 研究数据的事后分析表明,西那卡塞引起的低钙血症很常见,大多无症状,且会自发缓解。这些发现令人安心,可能需要治疗惰性。然而,甲状旁腺切除术患者的先前研究表明,从骨骼和心血管角度来看,补钙可能是有益且安全的,因此,对西那卡塞引起的低钙血症采取“坐视不管”的态度是否合适值得怀疑。

相似文献

1
Facing cinacalcet-induced hypocalcemia: sit back and relax?面对西那卡塞引起的低钙血症:坐视不管,放松心情?
Kidney Int. 2018 Jun;93(6):1275-1277. doi: 10.1016/j.kint.2018.01.038.
2
Incidence, predictors and therapeutic consequences of hypocalcemia in patients treated with cinacalcet in the EVOLVE trial.EVOLVE 试验中使用西那卡塞治疗的患者低钙血症的发生率、预测因素和治疗后果。
Kidney Int. 2018 Jun;93(6):1475-1482. doi: 10.1016/j.kint.2017.12.014. Epub 2018 Mar 7.
3
Impact of cinacalcet hydrochloride on bone histology in patients with secondary hyperparathyroidism.盐酸西那卡塞对继发性甲状旁腺功能亢进患者骨组织学的影响。
Ther Apher Dial. 2008 Oct;12 Suppl 1:S38-43. doi: 10.1111/j.1744-9987.2008.00630.x.
4
Cinacalcet HCl: a novel treatment for secondary hyperparathyroidism caused by chronic kidney disease.盐酸西那卡塞:一种治疗慢性肾脏病所致继发性甲状旁腺功能亢进的新疗法。
J Ren Nutr. 2006 Jul;16(3):253-8. doi: 10.1053/j.jrn.2006.04.010.
5
Effect of paricalcitol and cinacalcet on serum phosphate, FGF-23, and bone in rats with chronic kidney disease.帕立骨化醇和西那卡塞对慢性肾脏病大鼠血清磷酸盐、FGF-23 和骨的影响。
Am J Physiol Renal Physiol. 2010 Jun;298(6):F1315-22. doi: 10.1152/ajprenal.00552.2009. Epub 2010 Mar 3.
6
Cinacalcet-induced hungry bone syndrome.西那卡塞诱发的饥饿骨综合征。
Semin Dial. 2007 Jan-Feb;20(1):83-5. doi: 10.1111/j.1525-139X.2007.00248.x.
7
Cinacalcet-induced hypocalcemia in a cohort of European haemodialysis patients: predictors, therapeutic approaches and outcomes.西那卡塞致欧洲血液透析患者低钙血症的队列研究:预测因素、治疗方法及结局。
J Nephrol. 2020 Aug;33(4):803-816. doi: 10.1007/s40620-019-00686-z. Epub 2019 Dec 17.
8
[Therapeutic agents for disorders of bone and calcium metabolism. The calcimimetic cinacalcet HCl].[用于骨骼和钙代谢紊乱的治疗药物。拟钙剂盐酸西那卡塞]
Clin Calcium. 2007 Jan;17(1):88-92.
9
Cinacalcet for secondary hyperparathyroidism in hemodialysis recipients.西那卡塞用于血液透析患者的继发性甲状旁腺功能亢进症
N Engl J Med. 2004 Jul 8;351(2):188-9; author reply 188-9.
10
Cinacalcet: An oral calcimimetic agent for the management of hyperparathyroidism.西那卡塞:一种用于治疗甲状旁腺功能亢进的口服拟钙剂。
Clin Ther. 2005 Nov;27(11):1725-51. doi: 10.1016/j.clinthera.2005.11.015.

引用本文的文献

1
Pre-operative Cinacalcet Administration Reduces Immediate Post-operative Hypocalcemia Following Total Parathyroidectomy in Severe Renal Hyperparathyroidism.术前西那卡塞给药可减少重度甲状旁腺功能亢进症患者甲状旁腺全切除术后即刻低钙血症。
World J Surg. 2023 Aug;47(8):1986-1994. doi: 10.1007/s00268-023-07030-4. Epub 2023 May 4.
2
Pharmacogenetic and safety analysis of cinacalcet hydrochloride in healthy Chinese subjects.健康中国受试者中盐酸西那卡塞的药物遗传学与安全性分析。
Ann Transl Med. 2020 Nov;8(21):1385. doi: 10.21037/atm-20-1329.
3
Cinacalcet-induced hypocalcemia in a cohort of European haemodialysis patients: predictors, therapeutic approaches and outcomes.
西那卡塞致欧洲血液透析患者低钙血症的队列研究:预测因素、治疗方法及结局。
J Nephrol. 2020 Aug;33(4):803-816. doi: 10.1007/s40620-019-00686-z. Epub 2019 Dec 17.
4
The dietary management of calcium and phosphate in children with CKD stages 2-5 and on dialysis-clinical practice recommendation from the Pediatric Renal Nutrition Taskforce.儿童 CKD 2-5 期和透析患者的钙和磷饮食管理-儿科肾脏营养工作组的临床实践建议。
Pediatr Nephrol. 2020 Mar;35(3):501-518. doi: 10.1007/s00467-019-04370-z. Epub 2019 Oct 30.
5
The impact of cinacalcet in the mineral metabolism markers of patients on dialysis with severe secondary hyperparathyroidism.西那卡塞对重度继发性甲状旁腺功能亢进透析患者矿物质代谢标志物的影响。
J Bras Nefrol. 2019 Jul 18;41(3):336-344. doi: 10.1590/2175-8239-JBN-2018-0219.